Truscreen - Latest News [Page 1]

Truscreen Announces Capital Raising

Wednesday, 22 March 2017, 10:10 am | Truscreen

Cervical cancer technology company, TruScreen Limited (NZAX:TRU) has undertaken a $4.09 million share placement to institutional and other select investors as it looks to strengthen its balance sheet and fund commercial growth. In addition to the placement, ... More >>

Truscreen Gains Access to India Market

Tuesday, 7 March 2017, 10:36 am | Truscreen

Cervical cancer technology company, TruScreen Limited (NZAX:TRU), has entered into commercial agreements with Khandelwal Laboratories Pvt Limited ( K.Lab) for the purpose of providing TruScreen with access to the Indian market. India is the world’s largest ... More >>

Truscreen Update – Europe And Other Markets

Monday, 6 March 2017, 12:21 pm | Truscreen

Cervical cancer technology company, TruScreen Limited (NZAX: TRU), the manufacturer of real time cervical cancer screening technology, advises that it has entered into distribution agreements for the sale of its TruScreen device in multiple new markets. ... More >>

Truscreen Preliminary Unaudited Financial Results

Tuesday, 14 June 2016, 11:37 am | Truscreen

TruScreen (NZX: TRU), the world’s only CE certified manufacturer of an electro-light tissue differentiating device for the detection of cervical cancer, today released its preliminary unaudited financial results for the year ended 31 March 2016. More >>

Truscreen Selected For Major Chinese Screening Programme

Tuesday, 31 May 2016, 11:11 am | Truscreen

Cancer technology company TruScreen Limited (NZAX: TRU) advises that its technology has been selected for use in a major cervical cancer screening programme in North China. More >>

TRUSCREEN COMMENCES EXPORT OF SECOND GENERATION DEVICE

Monday, 2 May 2016, 12:13 pm | Truscreen

Cancer technology company TruScreen Limited (NZAX: TRU) advises that supply and export of its second generation cervical cancer screening device, known as TruScreen Ultra, has commenced with initial shipments to Latin America (Mexico) and the Middle East ... More >>

Certification for Truscreen 2nd Generation Device

Friday, 15 April 2016, 2:40 pm | Truscreen

Cancer technology company, TruScreen Limited (NZAX:TRU) advises that its second generation cervical cancer screening device, known as “TruScreen Ultra”, is now ready for commercial launch in select markets following receipt of CE Mark certification. This ... More >>

TruScreen Share Purchase Plan Exceeds Target

Wednesday, 1 July 2015, 11:14 am | Truscreen

Kiwi cancer diagnostic company TruScreen (TRU) has surpassed its target of $1million of capital to be raised via a Share Purchase Plan (SPP) for New Zealand resident shareholders. More >>

Chinese Approval Opens Huge Market to Kiwi Tech Company

Thursday, 30 April 2015, 1:01 pm | Truscreen

TruScreen Limited (NZAX: TRU), a New Zealand company with a unique real time cervical cancer screening technology now has open access to a potential NZD $1 billion per annum market after receiving Chinese Food And Drug Administration (CFDA) approval ... More >>

 

InfoPages Links

 
 
 

LATEST HEADLINES

 
 
 
InfoPages
Search Scoop  
 
 
Powered by Vodafone
NZ independent news